Irving Institute for Clinical and Translational Research

New York, New York 10032

0 studies enrolling now · 2 studies all time

What they study most

Frontotemporal Dementia, Neurodegenerative Diseases

Studies at this site

• A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3) — Stopped early
• Continuation Study for Latozinemab — Stopped early